During this event we explored new developments in the early diagnosis of pancreatic cancer.

We began by looking at a study exploring what support GPs need to start using new pancreatic cancer tests as soon as they become available. We then heard about the world’s first breath test for pancreatic cancer. To finish, we found out about the development of a decision risk tool for early diagnosis of pancreatic cancer among new-onset diabetes in UK primary care. 

View the agenda

  • 18.00 – 18.05: Welcome and introduction – Chris Macdonald, Head of Research, Pancreatic Cancer UK
  • 18.05 – 18.15: Developing a toolkit to assess GP’s readiness to adopt new pancreatic cancer tests – Dr Patrick Kierkegaard, Team Leader – Cancer Technology Catalyst & Research Fellow, Imperial College London
  • 18.15 – 18.25: World’s first breath test – Professor George Hanna, Head of Department of Surgery and Cancer, Imperial College London
  • 18.25 – 18.35: Decision risk tool for early diagnosis in new-onset diabetes – Dr Ashley Clift, Clinical Research Fellow, University of Oxford
  • 18.35 – 18.55: Q&A
  • 19.00 – 19.00: Close

Who is this session for?

This event is open to all health professionals working with pancreatic cancer patients. It is particularly relevant to GPs and health professionals working in primary care.

Watch the presentations

Recording from New developments in pancreatic cancer- Early diagnosis

If you have any questions, please don’t hesitate to get in touch with us at hpnetwork@pancreaticcancer.org.uk